Back to News
Market Impact: 0.05
CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Source: globenewswire.com
Healthcare & BiotechManagement & Governance
CRISPR Therapeutics announced that senior management will present at Morgan Stanley's 24th Annual Global Healthcare Conference on September 14, 2026 at 1:05 p.m. The announcement contains no financial results, clinical updates, guidance, or other material business developments.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
CRSP0.10
More News
- SiTime director Katherine Schuelke resigns, board size reduced to eight
- Here are Friday's biggest analyst calls: Nvidia, SpaceX, CoreWeave, Deckers, Unusual Machines & more
- Vertex reports positive IgAN trial data, FDA decision due Nov. 30
- The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
- With earnings in rearview mirror, SpaceX-Tesla merger chatter takes center stage
- J&J prostate cancer drug shows promising tumor responses in early trial